Estimation of epidermal carcinogenic potency. 1990

R H McKee, and M J Nicolich, and R A Scala, and S C Lewis
Exxon Biomedical Sciences, Inc., East Millstone, New Jersey 08875-2350.

This report compared two statistical methods of estimating tumor latency, the Weibull distribution model and the Kaplan-Meier method. Parallelism of dose-response curves of different materials and quantitative reproducibility of dermal carcinogenesis data were also examined. The Weibull method has the advantage of producing parameter estimates, even when tumor yield is low. The Kaplan-Meier method, on the other hand, is free of distribution assumptions. Overall, since the comparisons of potency are made on the basis of parameters from the same assumed distribution on the same strain of animal, the Weibull estimates are favored. A comparison of dose-response data for benzo[a]pyrene and catalytically cracked clarified oil indicated that the slopes of the two dose-response curves were significantly different. Thus the relative carcinogenic potencies of different materials vary with dose, and potency comparisons must necessarily be dose-specific. The quantitative reproducibility of dermal carcinogenesis bioassays was also assessed. The dose-response curves from the three studies of one material had significantly different slopes. Thus the results suggested that there were sources of biological variability which could contribute to experimental error.

UI MeSH Term Description Entries
D008297 Male Males
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001564 Benzo(a)pyrene A potent mutagen and carcinogen. It is a public health concern because of its possible effects on industrial workers, as an environmental pollutant, an as a component of tobacco smoke. 3,4-Benzopyrene,3,4-Benzpyrene,3,4 Benzopyrene,3,4 Benzpyrene
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D015197 Carcinogenicity Tests Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values. Tumorigenicity Tests,Carcinogen Tests,Carcinogenesis Tests,Carcinogenic Activity Tests,Carcinogenic Potency Tests,Carcinogen Test,Carcinogenesis Test,Carcinogenic Activity Test,Carcinogenic Potency Test,Carcinogenicity Test,Potency Test, Carcinogenic,Potency Tests, Carcinogenic,Test, Carcinogen,Test, Carcinogenesis,Test, Carcinogenic Activity,Test, Carcinogenic Potency,Test, Carcinogenicity,Test, Tumorigenicity,Tests, Carcinogen,Tests, Carcinogenesis,Tests, Carcinogenic Activity,Tests, Carcinogenic Potency,Tests, Carcinogenicity,Tests, Tumorigenicity,Tumorigenicity Test
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

R H McKee, and M J Nicolich, and R A Scala, and S C Lewis
May 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology,
R H McKee, and M J Nicolich, and R A Scala, and S C Lewis
December 1990, Risk analysis : an official publication of the Society for Risk Analysis,
R H McKee, and M J Nicolich, and R A Scala, and S C Lewis
December 1985, Risk analysis : an official publication of the Society for Risk Analysis,
R H McKee, and M J Nicolich, and R A Scala, and S C Lewis
January 2008, Medical reference services quarterly,
R H McKee, and M J Nicolich, and R A Scala, and S C Lewis
August 1991, Archives of environmental contamination and toxicology,
R H McKee, and M J Nicolich, and R A Scala, and S C Lewis
February 1989, Environmental health perspectives,
R H McKee, and M J Nicolich, and R A Scala, and S C Lewis
January 1990, Progress in clinical and biological research,
R H McKee, and M J Nicolich, and R A Scala, and S C Lewis
January 1984, Food additives and contaminants,
R H McKee, and M J Nicolich, and R A Scala, and S C Lewis
August 1935, California and western medicine,
R H McKee, and M J Nicolich, and R A Scala, and S C Lewis
March 1965, Archives of environmental health,
Copied contents to your clipboard!